Table 4 Odds ratio of metabolic syndrome by PSQI and its components in females
From: Relationship between self-reported sleep quality and metabolic syndrome in general population
Score | n | OR | 95% CI | p value | |
|---|---|---|---|---|---|
Global PSQI score | ≤5 | 799 | 1.00 | (reference) | |
≥6 | 133 | 2.71 | (1.45-5.07) | 0.002 | |
Subjective sleep quality | 0 | 290 | 1.00 | (reference) | |
1 | 530 | 1.41 | (0.77-2.58) | 0.263 | |
2 | 108 | 1.55 | (0.59-4.08) | 0.378 | |
3 | 4 | 2.96 | (0.26-34.11) | 0.385 | |
Sleep latency | 0 | 555 | 1.00 | (reference) | |
1 | 261 | 1.65 | (0.86-3.16) | 0.131 | |
2 | 85 | 3.82 | (1.81-8.09) | <0.001 | |
3 | 31 | 5.95 | (2.17-16.34) | 0.001 | |
Sleep duration | 0 | 411 | 1.00 | (reference) | |
1 | 324 | 0.96 | (0.50-1.85) | 0.904 | |
2 | 186 | 1.57 | (0.81-3.06) | 0.185 | |
3 | 11 | 1.20 | (0.13-10.91) | 0.870 | |
Habitual sleep efficiency | 0 | 915 | 1.00 | (reference) | |
1 | 11 | 3.96 | (0.96-16.34) | 0.057 | |
2 | 4 | - | 0.999 | ||
3 | 2 | 10.42 | (0.61-176.68) | 0.105 | |
Sleep disturbance | 0 | 412 | 1.00 | (reference) | |
1 | 492 | 2.43 | (1.26-4.69) | 0.008 | |
2 | 27 | 3.84 | (1.17-12.65) | 0.027 | |
3 | 1 | - | |||
Use of sleep medication | 0 | 861 | 1.00 | (reference) | |
1 | 18 | 3.81 | (1.15-12.68) | 0.029 | |
2 | 10 | 1.12 | (0.13-9.86) | 0.916 | |
3 | 43 | 3.10 | (1.32-7.30) | 0.009 | |
Daytime dysfunction | 0 | 609 | 1.00 | (reference) | |
1 | 263 | 1.12 | (0.61-2.06) | 0.710 | |
2 | 52 | 0.75 | (0.16-3.52) | 0.718 | |
3 | 8 | 6.27 | (1.24-31.79) | 0.027 |